Official manufacturer savings cards, self-pay pharmacies, Medicare, and assistance programs.
Savings & cost programsEli Lilly's direct-to-patient pharmacy for Zepbound, Foundayo, and other Lilly medicines, with home delivery.
Why it helps on a GLP-1: Self-pay Zepbound vials and KwikPens start at $299/month for the starter dose, and Foundayo pills start at $149/month—no insurance needed (prescription required).
Savings & cost programsLilly's official savings program for Zepbound, plus self-pay and Medicare options on one page.
Why it helps on a GLP-1: With commercial insurance that covers Zepbound pens, eligible patients may pay as little as $25 for up to a 3-month fill. Government insurance excluded.
Savings & cost programsLilly's official copay card for Mounjaro (tirzepatide) for type 2 diabetes.
Why it helps on a GLP-1: Eligible commercially insured patients may pay as little as $25 for up to a 3-month prescription. Government insurance excluded.
Savings & cost programsNovo Nordisk's own pharmacy for self-pay Wegovy (pen and pill) and Ozempic, delivered to your door.
Why it helps on a GLP-1: New patients pay $199/month for the first two fills of the two lowest Wegovy pen doses (through 12/31/2026), then $349/month; Wegovy pill starts at $149/month.
Savings & cost programsNovo Nordisk's official savings program for Wegovy with commercial insurance or self-pay.
Why it helps on a GLP-1: Brings the cash price down at local pharmacies too, not just home delivery—useful if you'd rather pick up in person.
Savings & cost programsOfficial cost and savings page for Ozempic (semaglutide) pen and pill.
Why it helps on a GLP-1: Eligible commercially insured patients may pay as little as $25/month; the page also lists self-pay options.
Savings & cost programsFederal website listing negotiated cash prices for brand-name GLP-1s and linking to each maker's program.
Why it helps on a GLP-1: A quick way to compare starting cash prices for Wegovy, Ozempic, Zepbound, and Foundayo in one place. It doesn't sell drugs itself.
Savings & cost programsTemporary Medicare program (from July 1, 2026) covering Wegovy, Zepbound KwikPen, and Foundayo for eligible Part D enrollees.
Why it helps on a GLP-1: Eligible people with Medicare drug coverage pay a $50 monthly copay. Check the BMI and health-condition criteria on Medicare.gov.
Savings & cost programsFree Novo Nordisk medicines for people who qualify based on income and coverage.
Why it helps on a GLP-1: If you're uninsured or on Medicare with limited income, this may cover certain Novo medicines at no cost—check the current covered-medicine list.
Savings & cost programsNonprofit patient assistance program providing prescribed Lilly medicines free for up to 12 months to qualifying patients.
Why it helps on a GLP-1: For people with financial need—check the available-medications list to see what's currently covered.